Evaluation of Two Treatments for Chronic Post Concussion Syndrome

NCT00871884 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-01-22

No results posted yet for this study

Summary

This study is designed to investigate factors that are associated with prolonged recovery from mild head injury. The investigators are particularly interested in defining the impact of anxiety related variables, such as health anxiety and anxiety sensitivity in the maintenance of symptoms.

A further goal of the study is the evaluation of two treatment methods that have been proposed to be effective in reducing the impact of post concussion symptoms. The investigators hypothesize that a treatment which is directly focused on changing these anxiety related variables will be more effective than one that does not.

Conditions

  • Post Concussion Syndrome
  • Head Injury

Interventions

BEHAVIORAL

Psychoeducation

Education about the common prognostic considerations, normal symptoms experienced and etiology of symptoms following mild head injury. Includes some basic suggestions surrounding methods to diminish the impact of symptoms on one's life.

BEHAVIORAL

Relaxation Training

Includes Progressive Muscle Relaxation, Guided Visualization, and various other relaxation techniques to induce deep relaxation.

BEHAVIORAL

Interoceptive Exposure

Includes a variety of exercises used to elicit somatic sensations which may be feared by the participant, in an attempt to extinguish or lessen the fear reaction to these sensations.

Sponsors & Collaborators

  • Simon Fraser University

    lead OTHER

Principal Investigators

  • Kevin C Whitfield, M.A. · Human Neuropsychology Laboratory, Department of Psychology, Simon Fraser University

  • Allen E Thornton, Ph.D. · Human Neuropsychology Laboratory, Department of Psychology, Simon Fraser University

  • Alex P Chapman, Ph.D. · Department of Psychology, Simon fraser University

  • David Cox, Ph.D. · Department of Psychology, Simon Fraser University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00871884 on ClinicalTrials.gov